- Screening-preventable cervical cancer risks: Evidence from a nationwide audit in Sweden
[作者:Andrae, B; Kemetli, L; Sparen, P; Silfverdal, L; Strander, B; Ryd, W; Dillner, J; Tornberg, S,期刊:Journal of the National Cancer Institute, 页码:622-629 , 文章类型: Article,,卷期:2008年100-9]
- Background The effectiveness of cervical cancer screening programs differs widely in different populations. The reasons for these differences are unclear. Routine and comprehensive audits have been proposed as an ethical...
- Cost of care for elderly cancer patients in the United States
[作者:Yabroff, KR; Lamont, EB; Mariotto, A; Warren, JL; Topor, M; Meekins, A; Brown, ML,期刊:Journal of the National Cancer Institute, 页码:630-641 , 文章类型: Article,,卷期:2008年100-9]
- Background Timely estimates of the costs of care for cancer patients are an important element in the formulation of national cancer programs and policies. We estimated net costs of care for elderly cancer patients in the...
- Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibody
[作者:Shanker, A; Brooks, AD; Tristan, CA; Wine, JW; Elliott, PJ; Yagita, H; Takeda, K; Smyth, MJ; Murphy, WJ; Sayers, TJ,期刊:Journal of the National Cancer Institute, 页码:649-662 , 文章类型: Article,,卷期:2008年100-9]
- Background Resistance of tumors to cell death signals poses a complex clinical problem. We explored the therapeutic potential and in vivo toxicity of a combination of bortezomib, a proteasome inhibitor, and MD5-1, a tumo...
- Persistent organochlorine pesticides and risk of testicular germ cell tumors
[作者:McGlynn, KA; Quraishi, SM; Graubard, BI; Weber, JP; Rubertone, MV; Erickson, RL,期刊:Journal of the National Cancer Institute, 页码:663-671 , 文章类型: Article,,卷期:2008年100-9]
- Background Exposure to endocrine-disrupting chemicals, such as persistent organochlorine pesticides, has been suggested to increase the risk of testicular germ cell tumors (TGCTs).Methods To study the relationship of POP...
- Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
[作者:Li, XX; Lewis, MT; Huang, J; Gutierrez, C; Osborne, CK; Wu, MF; Hilsenbeck, SG; Pavlick, A; Zhang, XM; Chamness, GC; Wong, H; Rosen, J; Chang, JC,期刊:Journal of the National Cancer Institute, 页码:672-679 , 文章类型: Article,,卷期:2008年100-9]
- Background Tumorigenic breast cancer cells that express high levels of CD44 and low or undetectable levels of CD24 (CD44(+)/CD24(-/low)) may be resistant to chemotherapy and therefore responsible for cancer relapse. Thes...
|